약학회지 (YAKHAK HOEJI)

  • 제57권2호
  • /
  • Pages.125-131
  • /
  • 2013
  • /
  • 0377-9556(pISSN)
  • /
  • 2383-9457(eISSN)
대한약학회 (The Pharmaceutical Society of Korea)
권호 표지

파지 디스플레이를 이용한 피부 투과 기능성 펩타이드의 개발

Selection of Skin-Penetrating Peptide Using Phage Display

  • 투고 : 2013.03.08
  • 심사 : 2013.04.24
  • 발행 : 2013.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Biologically active peptides, including growth factors and cytokines, participate in various biological processes in human skin. They could provide a great advantage of maintaining healthy skin. Many peptide growth factors like epidermal growth factor (EGF) and human growth hormone (hGH) have been used in cosmetic formulations. The delivery of peptide growth factors across the Stratum corneum, however, seems not sufficient because of their physical properties such as high molecular weight and hydrophilicity. So increasing the penetration of growth factors of interest into skin would be a major concern for ensuring their maximum biological efficacy. In this study, we have identified several skin penetration-enhancing peptides which facilitate delivery of growth factors, when fused at N-terminus of the target protein, into skin. For efficient and rapid screening, we constructed a skin-penetrating assay system using Franz cell and porcine skin. Next, we carried out phage display screening using M-13 bacteriophage with random 12 -amino acid library on its coat protein P3 on that system. After several selection rounds, peptide sequences facilitate the penetration of phages through the porcine skin were identified from a large population of phages. We found that phages with the most potent peptide (S3-2, NGSLNTHLAPIL) could penetrate the porcine skin eight times more than those with control peptide (12 mino acids scrambled peptide). Furthermore, growth factors conjugated with S3-2 peptide penetrate porcine skin three to five times efficiently than non-conjugated growth factors. In conclusion, our data shows that the skin penetration-enhancing peptide we have characterized could increase the delivery of growth factors and is useful for cosmeceutical application.

키워드

참고문헌

  1. Pastore, S., Mascia, F., Mariani, V. and Girolomoni, G. : The epidermal growth factor receptor system in skin repair and inflammation. J. Invest. Dermatol. 128, 1365 (2008). https://doi.org/10.1038/sj.jid.5701184
  2. Hudson, L. G. and McCawley, L. J. : Contributions of the epidermal growth factor receptor to keratinocyte motility. Microsc. Res. Tech. 43, 444 (1998). https://doi.org/10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C
  3. Eming, S. A., Krieg, T. and Davidson, J. M. : Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127, 514 (2007). https://doi.org/10.1038/sj.jid.5700701
  4. Werner, S., Krieg, T. and Smola, H. : Keratinocyte-fibroblast interactions in wound healing. J. Invest. Dermatol. 127, 998 (2007). https://doi.org/10.1038/sj.jid.5700786
  5. Ansel, J., Perry, P., Brown, J., Damm, D., Phan, T., Hart, C., Luger, T. and Hefeneider, S. : Cytokine modulation of keratinocyte cytokines. J. Invest. Dermatol. 94, 101S (1990). https://doi.org/10.1111/1523-1747.ep12876053
  6. Sundaram, H. : Role of physiologically balanced growth factors in skin rejuvenation. J. Drugs Dermatol. 8, 3 (2009).
  7. Mehta, R. C. and Fitzpatrick, R. E. : Endogenous growth factors as cosmeceuticals. Dermatol. Ther. 20, 350 (2007). https://doi.org/10.1111/j.1529-8019.2007.00149.x
  8. Menon, G. K. : New insights into skin structure: scratching the surface. Advanced Drug Delivery Reviews 54, Supplement, S3 (2002). https://doi.org/10.1016/S0169-409X(02)00121-7
  9. Kanikkannan, N., Kandimalla, K., Lamba, S. S. and Singh, M. : Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr. Med. Chem. 7, 593 (2000). https://doi.org/10.2174/0929867003374840
  10. Benson, H. A. : Transdermal drug delivery: penetration enhancement techniques. Curr. Drug. Deliv. 2, 23 (2005). https://doi.org/10.2174/1567201052772915
  11. Boelsma, E., Tanojo, H., Bodde, H. E. and Ponec, M. : Assessment of the potential irritancy of oleic acid on human skin: Evaluation in vitro and in vivo. Toxicol. In Vitro 10, 729 (1996). https://doi.org/10.1016/S0887-2333(96)00053-7
  12. Aungst, B. J., Blake, J. A. and Hussain, M. A. : Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 7, 712 (1990). https://doi.org/10.1023/A:1015859320604
  13. Eguchi, A., Akuta, T., Okuyama, H., Senda, T., Yokoi, H., Inokuchi, H., Fujita, S., Hayakawa, T., Takeda, K., Hasegawa, M. and Nakanishi, M. : Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276, 26204 (2001). https://doi.org/10.1074/jbc.M010625200
  14. Ye, N., Lin, Y., Pan, J., Liu, S. and Rao, P. : [PTD mediated protein transduction technology and its application in medical field]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 28, 401 (2011).
  15. Kim, Y. C., Ludovice, P. J. and Prausnitz, M. R.: Transdermal delivery enhanced by magainin pore-forming peptide. J. Control Release 122, 375 (2007) https://doi.org/10.1016/j.jconrel.2007.05.031
  16. Schmitz, U., Versmold, A., Kaufmann, P. and Frank, H. G. : Phage display: a molecular tool for the generation of antibodies--a review. Placenta. 21 Suppl A, S106 (2000). https://doi.org/10.1053/plac.1999.0511
  17. Schmook, F. P., Meingassner, J. G. and Billich, A. : Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int. J. Pharm. 215, 51 (2001). https://doi.org/10.1016/S0378-5173(00)00665-7
  18. Barbero, A. M. and Frasch, H. F. : Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review. Toxicology In Vitro 23, 1 (2009). https://doi.org/10.1016/j.tiv.2008.10.008
  19. Simon, G. A. and Maibach, H. I. : The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations--an overview. Skin Pharmacol. Appl. Skin Physiol. 13, 229 (2000). https://doi.org/10.1159/000029928
  20. Prausnitz, M. R. : A peptide chaperone for transdermal drug delivery. Nat. Biotechnol. 24, 416 (2006). https://doi.org/10.1038/nbt0406-416
  21. Beckmann, M. W., Tutschek, B., Gohring, U. J., Engels, K., Picard, F. K., Scharl, A., Niederacher, D. and Schnurch, H. G. : [Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance]. Geburtshilfe Frauenheilkd. 55, 258 (1995). https://doi.org/10.1055/s-2007-1023314
  22. Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F. M., Schlessinger, J. and Wagner, E. F. : The EGF receptor provides an essential survival signal for SOSdependent skin tumor development. Cell. 102, 211 (2000). https://doi.org/10.1016/S0092-8674(00)00026-X
  23. Bernerd, F., Marionnet, C. and Duval, C. : Solar ultraviolet radiation induces biological alterations in human skin in vitro: relevance of a well-balanced UVA/UVB protection. Indian J. Dermatol. Venereol. Leprol. 78 Suppl 1, S15 (2012). https://doi.org/10.4103/0378-6323.97351